Pfiz­er, My­lan deal takes a coro­n­avirus hit

Apart from R&D dis­rup­tion, an­oth­er ca­su­al­ty of the coro­n­avirus epi­dem­ic is deal­mak­ing, or in this case, com­plet­ing planned merg­ers. In Ju­ly 2019, Pfiz­er — My­lan’s man­u­fac­tur­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER